Vancomycin disposition and penetration into ventricular fluid of the central nervous system following intravenous therapy in patients with cerebrospinal devices

Pediatric Neurosurgery

Volumn 43, Issue 6, 2007, Pages 449-455

  Jorgenson, Laney ^a   Reiter, Pamela D ^a   Freeman, Jane E ^a   Winston, Ken R ^a   Fish, Douglas ^b   McBride, Lori A ^c   Handler, Michael H ^a  

^a CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Pharmacokinetics, children; Vancomycin concentrations, central nervous system

Indexed keywords

ANTIBIOTIC AGENT; VANCOMYCIN;

ADOLESCENT; ANTIBIOTIC PROPHYLAXIS; AREA UNDER THE CURVE; ARTICLE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID SHUNTING; CHILD; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; DEVICE; DRUG CEREBROSPINAL FLUID LEVEL; DRUG DETERMINATION; DRUG DISPOSITION; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG PENETRATION; FEMALE; HUMAN; INFANT; INFECTION PREVENTION; MALE; NEWBORN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SHUNT; SHUNT INFECTION; SINGLE DRUG DOSE;

ADOLESCENT; ADULT; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID SHUNTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; MALE; METABOLIC CLEARANCE RATE; PROSPECTIVE STUDIES; VANCOMYCIN;

EID: 36049007100     PISSN: 10162291     EISSN: None     Source Type: Journal    
DOI: 10.1159/000108786     Document Type: Article

References (17)

1. Bell WO: Management of infected cerebral spinal fluid shunts in children. Contemp Neurosurg 1992;14:1-6.
2. Bayston R, Hart CA, Barnicoat M: Intraventricular vancomycin in the treatment of ventriculitis associated with cerebrospinal fluid shunting and drainage. J Neurol Neurosurg Psychiatry 1987;50:1419-1423.
3. Craig WA: Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid. Infect Dis Clin North Am 2003;17:479-501.
4. Lustar I, McCraken GH, Friedland IR: Antibiotics in the cerebrospinal fluid. Clin Infectious Disease 1998;27:1117-1129.
5. Ronan A, Hogg GG, Klug GL: Cerebral fluid shunt infections in children. Pediatr Infect Dis J 1995;14:782-786.
6. National Nosocomial Infections Surveillance System: National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470-485.
7. Schaad UB, McCracken GH, Nelson JD: Clinical pharmacology and efficacy of vancomycin in pediatric patients. J Pediatr 1980;96:119-126.
8. Chowdhury MH, Tunkel AR: Antibacterial agents in infections of the central nervous system. Infect Dis North Am 2000;14:391-408.
9. Fan-Harvard P, Nahara MC, Bartkowski MH, Barson WJ, Kosnik EJ: Pharmacokinetics and cerebrospinal fluid concentrations of vancomycin in pediatric patients undergoing CSF shunt placement. Chemotherapy 1990;36:103-108.
10. Leroux P, Howard MA, Winn HR: Vancomycin pharmacokinetics in hydrocephalic shunt prophylaxis and relationship to ventricular volume. Surg Neurol 1990;34:366-372.
11. Luer MS, Hatton J: Vancomycin administration into the cerebrospinal fluid: a review. Ann Pharmacother 1993;27:912-921.
12. Schaad UB, Nelson JD, McCracken JH: Pharmacology and efficacy of vancomycin for staphylococcal infections in children. Rev Infect Dis 1981;3:S282-S288.
13. Pfaulsner B, Spiss H, Beer R, Kampfl A, Engelhardt K, Schober M, et al: Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy. J Neurosurg 2003;98:1040-1044.
14. National Committee for Clinical Laboratory Standards: Methods for Dilution Antimicrobial Susceptibility Test for Bacteria that Grow Aerobically, ed 6. Approved Standard M7-A6. Villanova, NCCLS, 2003.
15. Nagl M, Neher C, Hager J, Pfausler B, Schmutzhard E, Allerberger F: Bactericidal activity of vancomycin in cerebrospinal fluid. Antimicrob Agents Chemother 1999;43:1932-1934.
16. Reiter PD, Doron MW: Vancomycin cerebrospinal fluid concentrations after intravenous administration in premature infants. J Perinatol 1996;16:331-335.
17. McGee SM, Kaplan SL, Mason EO, et al: Ventricular fluid concentrations of vancomycin in children after intravenous and intraventricular administration. Pediatr Infect Dis J 1990;9:138-139.